Trinity Biotech Regains Nasdaq Compliance
Ticker: TRIB · Form: 6-K · Filed: Nov 7, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Nov 7, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: compliance, listing-requirements, press-release
Related Tickers: TRIN
TL;DR
Trinity Biotech back on Nasdaq's good side, shares should hold steady.
AI Summary
Trinity Biotech PLC announced on November 7, 2024, that it has regained compliance with Nasdaq's listing requirements. This filing includes a press release detailing this positive development.
Why It Matters
Regaining Nasdaq compliance is crucial for Trinity Biotech as it ensures the company's shares can continue to be traded on the exchange, maintaining liquidity and investor confidence.
Risk Assessment
Risk Level: low — The filing is a routine announcement of compliance, indicating a positive resolution to a previous concern.
Key Players & Entities
- Trinity Biotech PLC (company) — Registrant
- Nasdaq (company) — Stock Exchange
- November 7, 2024 (date) — Date of Press Release
FAQ
What specific Nasdaq listing requirements did Trinity Biotech regain compliance with?
The filing states that Trinity Biotech regained compliance with Nasdaq's listing requirements, but does not specify which particular requirements were met in this document.
When was the press release announcing compliance issued?
The press release announcing Trinity Biotech's regained compliance with Nasdaq listing requirements was issued on November 7, 2024.
What is the primary purpose of this 6-K filing?
The primary purpose of this 6-K filing is to report a press release issued by Trinity Biotech PLC announcing its regained compliance with Nasdaq's listing requirements.
Is Trinity Biotech filing a Form 20-F or 40-F?
Trinity Biotech indicated that it files annual reports under cover of Form 20-F.
Where is Trinity Biotech's principal executive office located?
Trinity Biotech's principal executive office is located at IDA Business Park, Bray, County Wicklow, Ireland.
Filing Stats: 177 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2024-11-07 12:33:01
Filing Documents
- zk2432250.htm (6-K) — 13KB
- exhibit_99-1.htm (EX-99.1) — 12KB
- image1.jpg (GRAPHIC) — 90KB
- 0001178913-24-003523.txt ( ) — 151KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Louise Tallon Louise Tallon Chief Financial Officer Date: November 7, 2024